Navigating the Future of AI in Pharma: AI agents will need limitations
Audio is streamed directly from the publisher (podtrac.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
AI has revolutionized drug discovery by enabling scientists to process vast amounts of historical data, thus accelerating the identification of disease targets and molecule development. AI helps avoid past mistakes and improves the quality of research, making it an indispensable tool in the lab. MSD's approach to AI involves a blend of internal talent and strategic partnerships. By combining computational and web science expertise, MSD ensures that both technological and scientific endpoints are effectively addressed, says Matt Studney, SVP of Research Labs at MSD. Topics addressed: Internal vs. External AI Development at MSD Global Data Management Challenges Generative AI's Impact on Drug Discovery Confidential AI Systems and Documentation Challenges in AI Integration Workforce Upskilling and Cultural Change Future Breakthroughs and Concerns Synthetic Data and Drug Repurposing www.facesofdigitalhealth.com Newsletter: https://fodh.substack.com/
Youtube: https://youtu.be/pgCz-tgHaL0